Merck & Co., Inc. (MRK) operating KPIs

MRKNYSEPharmaceutical PreparationsFiscal year ends December 31

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 7, 2026Score 9/30242% above fair value

$146.33+5.40 (+3.83%)

Close on Oct 29, 2026Market cap $361.02BP/E 117.1Yield 2.24%

Merck deferred Income Taxes ($M) ($M)

Postgres DB financial_values

Quarterly Annual

Latest, FY2025

1,439

Period ended Dec 31, 2025

Change on a year earlier

+3.7%

1,387 in FY2024

History

15 years

Since FY2008

Sources

Documents cited below

Annual history

Hover a value to see the sentence it was read from; calculated values show their formula

Period	Ended	Deferred Income Taxes ($M) ($M)	Year on year	Source
FY2025	Dec 31, 2025	1,439	+3.7%	Form 10-K (filed 2026-02-24) ↗
FY2024	Dec 31, 2024	1,387	+59.2%	Form 10-K (filed 2025-02-25) ↗
FY2023	Dec 31, 2023	871	-51.5%	Form 10-K (filed 2024-02-26) ↗
FY2022	Dec 31, 2022	1,795	-47.8%	Form 10-K (filed 2023-02-24) ↗
FY2021	Dec 31, 2021	3,441	+242.4%	Form 10-K (filed 2022-02-25) ↗
FY2020	Dec 31, 2020	1,005	-31.6%	Form 10-Q (filed 2021-08-09) ↗
FY2019	Dec 31, 2019	1,470	-13.6%	Form 10-K (filed 2020-02-26) ↗
FY2018	Dec 31, 2018	1,702	-23.3%	Form 10-K (filed 2019-02-27) ↗
FY2017	Dec 31, 2017	2,219	-56.3%	Form 10-K (filed 2018-02-27) ↗
FY2016	Dec 31, 2016	5,077	-22.3%	SEC Filing ↗
FY2015	Dec 31, 2015	6,535	+46.3%	Form 10-K (filed 2016-02-26) ↗
FY2014	Dec 31, 2014	4,467	-34.1%	Form 10-K (filed 2016-02-26) ↗
FY2013	Dec 31, 2013	6,776	+18.0%	Form 10-K (filed 2014-02-27) ↗
FY2012	Dec 31, 2012	5,740	–	Form 10-K (filed 2014-02-27) ↗
FY2008	Dec 31, 2008	1,551	–	Form 10-Q (filed 2009-07-24) ↗

Cite this data

StockData. (2026). Merck Deferred Income Taxes ($M) ($M), annual FY2008–FY2025 [Data set]. Compiled from Merck SEC filings and investor materials. https://stockdatahq.com/stocks/mrk/kpis/db_bal_dtl

See every metric in the Merck KPI table. Data updated Oct 26, 2026.